Render Target: STATIC
Render Timestamp: 2024-11-08T09:42:50.098Z
Commit: 3c1f305a63297e594ac8d7bb5424007d592d68be
XML generation date: 2024-09-20 06:23:28.210
Product last modified at: 2024-07-30T13:00:12.952Z
1% for the planet logo
PDP - Template Name: Chemical Modulators
PDP - Template ID: *******c501c72

Nonactin #76040

    Product Information

    Product Usage Information

    Nonactin is supplied as a lyophilized powder. For a 10 mM stock, reconstitute 5 mg of powder in 0.68 mL of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.

    Storage

    Store lyophilized at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 2 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

    Product Description

    Molecular Weight 736.9 g/mol
    Purity >99%
    Molecular Formula C40H64O12
    CAS 6833-84-7
    Solubility Soluble in DMSO at 10 mg/mL or ethanol at 10 mg/mL.

    Background

    The antibiotic Nonactin is an ionophore that binds and transports monovalent cations (e.g., K+, NH4+, and Na+) across membranes through passive diffusion (1). Nonactin displays both antibacterial and anti-tumor activities, and inhibits drug efflux in multiple drug resistant cancers (2). Naturally occurring Nonactin is composed of four monomers of Nonactic acid, comprised of an equal number of (+) and (-) monomers. The antibiotic properties of Nonactin result from its ability to form stable complexes with monovalent cations; artificial Nonactin tetramers, comprised of either all (+) or all (-) Nonactic acid monomers, lack ion binding ability and are less potent antibiotics (3). Treatment of erythrocytes with Nonactin leads to suicidal erythrocyte death as evidenced by the shrinking of erythrocytes and translocation of phosphatidylserine from the erythrocyte interior to the cell surface (4). Nonactin selectively induces apoptosis and results in tumor regression in a β-catenin mutant HCT 116 xenograft model (5), and can inhibit the surface expression of endogenous HSP60 (6).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.